CapsoVision, Inc Proceeds from Issuance or Sale of Equity
CapsoVision, Inc (CV) reported Proceeds from Issuance or Sale of Equity of $202.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2025-08-14
- 2025-06-30: Proceeds from Issuance or Sale of Equity 6 month $202.00K.
- 2024-06-30: Proceeds from Issuance or Sale of Equity 6 month $72.00K.
| Period end | Proceeds from Issuance or Sale of Equity 6 month |
|---|---|
| 2025-06-30 | $202.00K 10-Q · filed 2025-08-14 |
| 2024-06-30 | $72.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |